BriaCell adds UCLA Health to phase 3 breast cancer trial
Tweet Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX) announced that UCLA Health Jonsson Comprehensive Cancer Center has joined its pivotal Phase 3 clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


